Your Medical Mind_ How to Decide What Is Right for You - Jerome Groopman [131]
Agency for Healthcare Research and Quality. “Effective health care: Comparative effectiveness of therapies for clinically localized prostate cancer.” Executive Summary (February 2008). http://www.effectivehealthcare.ahrq.gov/ehc/products/9/79/2008_0204ProstateCancerExecSum.pdf.
Ahmad, Jawad, et al. “Differences in access in liver transplantation: Disease severity, waiting time, and transplantation center volume.” Annals of Internal Medicine (Ann Intern Med) 146 (2007): 707–713.
Al Sibae, Mohamad R., and Mitchell S. Cappell. “Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleed, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.” Digestive Diseases and Sciences (Online First, September 1, 2010). DOI 10.1007/s10620-010-1390-3.
Andriole, Gerald L., et al. “Mortality results from a randomized prostate-cancer screening trial.” NEJM 360 (2009): 1310–1319.
Ariely, Dan. Predictably Irrational: The Hidden Forces That Shape Our Decisions. New York: HarperCollins, 2008.
———. The Upside of Irrationality: The Unexpected Benefits of Defying Logic at Work and at Home. New York: HarperCollins, 2010.
Armstrong, Lance. It’s Not About the Bike: My Journey Back to Life, Rei Rep ed. New York: Berkley Trade, 2001.
Atkinson, Simon, et al. “Identification of futility in intensive care.” Lancet 344 (1994): 1203–1206.
Avorn, Jerry. Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs. New York: Alfred A. Knopf, 2004.
Ball, W. W. Rouse. A Short Account of the History of Mathematics, 4th ed. Mineola, NY: Dover Publications, 2010.
Barry, Michael J. “Screening for prostate cancer: The controversy that refuses to die.” NEJM 360 (2009): 1351–1354.
Beasley, B. Nhi, Ellis F. Unger, and Robert Temple. “Anticoagulant options: Why the FDA approved a higher but not a lower dose of dabigatran.” NEJM (Online First, April 13, 2011).
Berwick, Donald. “My right knee.” Ann Intern Med 142 (2005): 121–125.
———. “What ‘patient-centered’ should mean: Confessions of an extremist.” Health Affairs—Web Exclusive 28, no. 4 (2009): W555—W565.
Berwick, Donald, et al. “Even good medical standards don’t apply in all cases.” Letters to the Editor. Wall Street Journal, April 15, 2009.
Bhattacharyya, Timothy, et al. “Measuring the report card: The validity of pay-for-performance metrics in orthopedic surgery.” Health Affairs 28 (2009): 526–532.
Bill-Axelson, Anna, et al. “Radical prostatectomy versus watchful waiting in early prostate cancer.” NEJM 352 (2005): 1977–1984.
Blumberg, Baruch S. “The Nobel Prize in Physiology or Medicine 1976.” Baruch S. Blumberg, Autobiography. http://nobelprize.org/nobel_prizes/medicine/laureates/1976/blumberg-autobio.html.
Blustein, Jeffrey. “Choosing for others as continuing a life story: The problem of personal identity revisited.” Journal of Law, Medicine & Ethics 27 (1999): 20–31.
Boyd, Norman F., et al. “Whose utilities for decision analysis?” Medical Decision Making 10 (1990): 58–67.
Brent, Gregory A. “Graves’ disease.” NEJM 358 (2008): 2594–2605.
Broedl, Uli C., Hans-Christian Geiss, and Klaus G. Parhofer. “Comparison of current guidelines for primary prevention of coronary heart disease.” Journal of General Internal Medicine (JGIM) 18 (2003): 190–195.
Brook, Robert H. “A physician = emotion + passion + science.” Journal of the American Medical Association (JAMA) 304 (2010): 2528–2529.
———. “The end of the quality improvement movement: Long live improving value.” JAMA 304 (2010): 1831–1832.
Bruni, Frank. “Death takes a rain check: How many blueberries a day does it take to keep the grim reaper away? An 87-year-old billionaire’s quest to live forever—or at least to 125.” New York Times Magazine, March 6, 2011.
Chapman, Gretchen B., et al. “Prostate cancer patients’ utilities for health states: How it looks depends on where you stand.” Medical Decision Making 18 (1998): 278–286.
Chapman, Gretchen B. “The psychology